Skip to main content
. 2017 Jun 23;40(9):1194–1202. doi: 10.2337/dc17-0238

Table 1.

Characteristics of HLA-eligible TEDDY children followed to age 6 years

IA negative (N = 7,914) Any IA (N = 589) IAA only (N = 252) GADA only (N = 226) IA-2A only (N = 9) Multiple IA (N = 102) Type 1 diabetes (N = 172)
Sex
 Female 3,928 (49.6) 264 (44.8) 108 (42.9) 105 (46.5) 2 (22.2) 49 (48.0) 85 (49.4)
 Male 3,986 (50.4) 325 (55.2) 144 (57.1) 121 (53.5) 7 (77.8) 53 (52.0) 87 (50.6)
Family history
 GP 7,112 (89.9) 465 (79.0) 196 (77.8) 183 (81.0) 7 (77.8) 79 (77.5) 118 (68.6)
 FDR mother 307 (3.9) 31 (5.3) 10 (4.0) 12 (5.3) 1 (11.1) 8 (7.8) 12 (7.0)
 FDR father 384 (4.9) 65 (11.0) 29 (11.5) 25 (11.1) 0 (0) 11 (10.8) 31 (18.0)
 FDR sibling 111 (1.4) 28 (4.8) 17 (6.8) 6 (2.7) 1 (11.1) 4 (3.9) 11 (6.4)
HLA
 DR3/3 1,706 (21.6) 76 (12.9) 17 (6.8) 54 (23.9) 1 (11.1) 4 (3.9) 18 (10.5)
 DR3/X 22 (0.3) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1 (0.6)
 DR3/4 3,019 (38.2) 298 (50.6) 125 (49.6) 111 (49.1) 3 (33.3) 59 (57.8) 97 (56.4)
 DR4/X 1,609 (20.3) 112 (19.0) 66 (26.2) 27 (12.0) 2 (22.2) 17 (16.7) 34 (19.8)
 DR4/4 1,558 (19.7) 103 (17.5) 44 (17.5) 34 (15.0) 3 (33.3) 22 (21.6) 22 (12.8)
Country
 U.S. 3,428 (43.3) 203 (34.5) 73 (29.0) 98 (43.4) 2 (22.2) 30 (29.4) 49 (28.5)
 Finland 1,658 (21.0) 144 (24.5) 78 (31.0) 40 (17.7) 2 (22.2) 24 (23.5) 54 (31.4)
 Germany 525 (6.6) 48 (8.2) 20 (7.9) 10 (4.4) 1 (11.1) 17 (16.7) 25 (14.5)
 Sweden 2,303 (29.1) 194 (32.9) 81 (32.1) 78 (34.5) 4 (44.4) 31 (30.4) 44 (25.6)
Started probiotics
 No or age >365 days 6,290 (78.5) 453 (76.9) 191 (75.8) 182 (80.5) 7 (77.8) 73 (71.6) 124 (72.1)
 Yes, age 28–365 days 1,077 (13.6) 100 (17.0) 46 (18.3) 33 (14.6) 1 (1.1) 20 (19.6) 33 (19.2)
 Yes, age <28 days 547 (6.9) 36 (6.1) 15 (6.0) 11 (4.9) 1 (11.1) 9 (8.8) 15 (8.7)
Maternal IA
 No 7,702 (97.3) 568 (96.4) 243 (96.4) 220 (97.4) 8 (88.9) 97 (95.1) 162 (94.2)
 Yes 212 (2.7) 21 (3.6) 9 (3.6) 6 (2.7) 1 (11.1) 5 (4.9) 10 (5.8)
Weight at 12 months, mean z score (SD) −0.13 (1.02) 0.00 (1.05) −0.06 (1.05) 0.11 (1.09) 0.03 (1.08) −0.11 (0.96) −0.06 (1.05)
Child conditions before first clinical visit (age 3 months)
 Upper resp. (yes) 1,857 (23.5) 144 (24.5) 68 (27.0) 47 (20.8) 3 (33.3) 26 (26.0) 50 (29.2)
 Lower resp. (yes) 970 (12.3) 66 (11.2) 27 (10.7) 31 (13.9) 2 (22.2) 6 (5.9) 16 (9.4)
 Diarrhea (yes) 740 (9.4) 52 (8.9) 26 (10.4) 16 (7.1) 0 (0) 10 (9.8) 14 (8.1)
 Rash (yes) 1,804 (22.8) 126 (21.4) 55 (21.8) 42 (18.7) 2 (22.2) 27 (26.5) 27 (15.7)
rs689 (INS)
 No 3,721 (53.7) 381 (65.6) 182 (73.4) 120 (53.6) 8 (88.9) 71 (71.0) 116 (72.1)
 Yes 3,206 (46.3) 200 (34.4) 66 (26.6) 104 (46.4) 1 (11.1) 29 (29.0) 45 (28.0)
rs231775 (CTLA4)
 No 2,176 (31.4) 174 (30.0) 80 (32.3) 56 (25.0) 3 (33.3) 35 (35.0) 46 (28.6)
 Yes 4,751 (68.6) 407 (70.1) 168 (67.7) 168 (75.0) 6 (66.7) 65 (65.0) 115 (71.4)
rs2476601 (PTPN22)
 No 5,550 (80.1) 401 (69.1) 168 (67.7) 159 (71.3) 5 (55.6) 69 (69.0) 103 (63.9)
 Yes 1,376 (19.9) 179 (30.9) 80 (32.3) 64 (28.7) 4 (44.4) 31 (31.0) 58 (26.0)
rs2816316 (RGS1)
 No 4,271 (66.9) 360 (66.5) 160 (68.7) 140 (67.3) 5 (62.5) 55 (59.8) 107 (69.9)
 Yes 2,110 (33.1) 181 (33.5) 73 (31.3) 68 (32.7) 3 (37.5) 37 (40.2) 46 (30.1)
rs10517086
 No 3,281 (51.4) 259 (47.9) 111 (47.6) 106 (51.0) 3 (37.5) 39 (42.4) 58 (37.9)
 Yes 3,100 (48.6) 282 (52.1) 122 (52.4) 102 (49.0) 5 (62.5) 53 (57.6) 95 (62.1)
rs4948088 (COBL)
 No 5,801 (90.9) 508 (93.9) 221 (94.9) 192 (92.3) 8 (100) 87 (94.6) 144 (94.1)
 Yes 580 (9.1) 33 (6.1) 12 (5.1) 16 (7.7) 0 (0) 5 (5.4) 9 (5.9)
rs2292239 (ERBB3)
 No 2,964 (46.5) 200 (37.0) 87 (37.3) 71 (34.1) 5 (62.5) 37 (40.2) 50 (32.7)
 Yes 3,417 (53.6) 341 (63.0) 146 (62.7) 137 (65.9) 3 (37.5) 55 (59.8) 103 (67.3)
rs3184504 (SH2B3)
 No 2,022 (31.7) 129 (23.8) 62 (26.6) 41 (19.7) 1 (12.5) 25 (27.2) 40 (26.1)
 Yes 4,359 (68.3) 412 (76.2) 171 (73.4) 167 (80.3) 7 (87.5) 67 (72.8) 113 (73.9)
rs12708716 (CLEC16A)
 No 2,788 (43.8) 263 (48.6) 105 (45.1) 104 (50.0) 4 (50.0) 50 (54.4) 74 (48.4)
 Yes 3,577 (56.2) 278 (51.4) 128 (54.9) 104 (50.0) 4 (50.0) 42 (45.7) 79 (51.6)

Data are N (%) unless otherwise indicated. Lower resp., lower-respiratory infection; Upper resp., upper-respiratory infection.